Caren Deardorf

DNTH

Caren Deardorf serves as Chief Commercial Officer at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$42.0K

Net Position

Net Seller

$42.0K

Companies Traded

DNTH

Active Period

Sep 2021

1 total trades

Most Recent

Sell DNTH

Sep 20, 2021 · $42.0K

Caren Deardorf's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

1 · $42.0K

Total Shares Bought

Total Shares Sold

6,238

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 20, 2021	Sell	6,238	$6.73	$42.0K	13,762

Related Insiders

Paula Soteropoulos

director

DNTHSell · May 11, 2026

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Apr 10, 2026

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Mar 13, 2026

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Mar 13, 2026

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity